DWA
DRIO icon

Dorsey Wright & Associates’s DarioHealth DRIO Stock Holding History

Dorsey Wright & Associates’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-75
Closed -$28.8K – 316
2021
Q1 		$28.8K Buy
+75
New +$33.8K 0.34% 152

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CHM
Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
LC
L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dorsey Wright & Associates's DRIO Position: Q2 2021 in Review

Dorsey Wright & Associates sold out of DarioHealth (DRIO) in Q2 2021, closing a stake of 75 shares — an estimated $28.8K sold.

Dorsey Wright & Associates first reported a position in DRIO in Q1 2021 and held it in 1 quarter. The position peaked at $28.8K in Q1 2021. 58 funds tracked by Wall St. Rank hold DRIO as of Q2 2021.

  • Dorsey Wright & Associates reported no remaining DarioHealth position as of Q2 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 75 DarioHealth shares in Q2 2021, an estimated $28.8K.
  • Dorsey Wright & Associates first reported a position in DarioHealth in Q1 2021 and held it in 1 quarter.
  • Dorsey Wright & Associates's DarioHealth position peaked at $28.8K in Q1 2021.
  • 58 funds tracked by Wall St. Rank held DarioHealth as of Q2 2021.

Based on Dorsey Wright & Associates's 13F filing for Q2 2021, filed 23 Jul 2021.